MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer

被引：0
|
作者：
Z. Sun
N. Zhou
Q. Han
L. Zhao
C. Bai
Y. Chen
J. Zhou
R. C. Zhao
机构：
[1] Peking Union Medical College Hospital,Department of Oncology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Institute of Basic Medical Sciences Chinese Academy of Medical Sciences
[3] School of Basic Medicine Peking Union Medical College,Department of Digestion
[4] Peking Union Medical College Hospital,Center of Translational Medicine
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[6] Peking Union Medical College Hospital,undefined
来源：
Clinical and Translational Oncology | 2015年 / 17卷
关键词：
miR-197; 5-Fluorouracil; Resistance; Thymidylate synthase; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：876 / 883
页数：7
相关论文
共 50 条
  • [21] Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil
    Fernández-Contreras, ME
    De Ayala, BJ
    De Paredes, MLG
    Velasco, A
    Majano, PL
    Palacios, J
    Gamallo, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (04) : 877 - 885
  • [22] miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
    Li, Tao
    Gao, Feng
    Zhang, Xi-Peng
    ONCOLOGY REPORTS, 2015, 33 (02) : 607 - 614
  • [23] Thymidylate synthase expression and response to irinotecan/5-fluorouracil therapy in advanced colorectal cancer (CRC)
    Jhatakia, S.
    Miller, H. J.
    Sigal, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Thymidylate Synthase Gene Polymorphism and Survival of Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil
    Sulzyc-Bielicka, Violetta
    Bielicki, Dariusz
    Binczak-Kuleta, Agnieszka
    Kaczmarczyk, Mariusz
    Pioch, Wieslawa
    Machoy-Mokrzynska, Anna
    Ciechanowicz, Andrzej
    Golebiewska, Magdalena
    Drozdzik, Marek
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (11) : 799 - 806
  • [25] MECHANISMS OF INNATE RESISTANCE TO THYMIDYLATE SYNTHASE INHIBITION AFTER 5-FLUOROURACIL
    SPEARS, CP
    GUSTAVSSON, BG
    BERNE, M
    FROSING, R
    BERNSTEIN, L
    HAYES, AA
    CANCER RESEARCH, 1988, 48 (20) : 5894 - 5900
  • [26] Utility of Thymidylate Synthase Genotyping for 5-Fluorouracil Chemotherapy in a Large,Colorectal Cancer Cohort Study
    Elsberry, D.
    Welker, N. C.
    Cho, M.
    Kim, I.
    Wilson, A. R.
    Bronner, M. P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 915 - 916
  • [27] Association of 5-fluorouracil chemosensitivity with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in colorectal cancer
    Lee, S.
    Lee, W.
    Lim, S.
    Shin, J.
    Choi, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 92 - 92
  • [28] The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells
    Oguri, T
    Achiwa, H
    Bessho, Y
    Muramatsu, H
    Maeda, H
    Niimi, T
    Sato, S
    Ueda, R
    LUNG CANCER, 2005, 49 (03) : 345 - 351
  • [29] Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients
    Abdallah, Emne Ali
    Fanelli, Marcello Ferretti
    Cavicchioli Buim, Marcilei Eliza
    Machado Netto, Marcelo Calil
    Gasparini Junior, Jose Luiz
    Souza e Silva, Virgilio
    Abbade Dettino, Aldo Lourenco
    Mingues, Natalia Breve
    Romero, Juliana Valim
    Mendonca Ocea, Luciana Menezes
    Malagoli Rocha, Bruna Maria
    Alves, Vanessa Silva
    Araujo, Daniel Vilarim
    Domingos Chinen, Ludmilla Thome
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (06) : 1397 - 1405
  • [30] Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil
    Hitre, E
    Budai, B
    Adleff, V
    Czeglédi, F
    Horváth, Z
    Gyergyay, F
    Lövey, J
    Kovács, T
    Orosz, Z
    Láng, I
    Kásler, M
    Kralovánszky, J
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (10): : 723 - 730
12345